CM Life Sciences II Inc.

Status: Deal Closed
U=S+W/5 W=S@11.5
IPO Proceeds, $M $276.00M
IPO Date Feb 23, 2021
CEO Eli D. Casdin
Left Lead Jefferies
IPO Cash in Trust 100.0%
SPAC Tenor 24 months
IPO Sector Healthcare

Life sciences

IPO Geography Global
Target Company SomaLogic
Deal Announced Mar 29, 2021
Deal Size, $M $1,230.00M
Deal Sector Healthcare
Deal Geography US/Canada
SEC Filings www.sec.gov
Approval Vote Aug 31, 2021
Amendment Vote TBD
Closing Date Sep 1, 2021
Formerly CMII SLGC SLGCW

Sign up for Free Trial

No credit card required

Sign in for more on CM Life Sciences II Inc.:

  • Structure and cap table
  • 8 directors & officers
  • 21 filings and events
  • 1 underwriters
  • 6 deal advisors
  • 2 legal advisors
Structure

Sign in to view structure, cap table, and calendar of events.

Team
Name Age Title
Eli D. Casdin 47 Chief Executive Officer and Director
Keith A. Meister 47 Chairman
Brian Emes 38 Chief Financial Officer and Secretary
Shaun Rodriguez 42 Chief Strategy Officer
Kevin Conroy 55 Director
Troy Cox 56 Director
Jason Kelly 40 Director
Stephen Quake 51 Director

Sign in to view team biographies and more sponsor and affiliate data.

Advisors
Underwriters
Jefferies BR 24,000,000 units
24,000,000 units
Up-Front UW fee 2.00 %
Deferred UW fee 3.50 %

Sign in to view more advisor data.

Deal

Sign in to view merger details and deal financials.

Filings

Sign in to view 21 filings.

Shareholders

Sign in to view shareholders 13F filing data.